Key result
Transvenous pacemaker electrode placement resulted in elevated FDP levels in a subset of patients, suggesting subclinical thrombosis, whereas battery replacement alone caused no increase.
Why the study?
Does transvenous pacemaker and electrode placement cause elevated FDP levels indicative of subclinical thrombosis?
Observational (n=68)
Does transvenous pacemaker and electrode placement cause elevated FDP levels indicative of subclinical thrombosis?
Transvenous pacemaker electrode placement, but not battery replacement alone, is associated with elevated FDP levels, suggesting low-grade intravascular coagulation.
No takes yet. Share an insight, caveat, or question.
May signal subclinical thrombosis risk after transvenous lead placement; hypothesis-generating and should not yet change practice.
CHRISTOPOULOU‐COKKINOU et al. (1982) conducted an observational in Patients with transvenous pacemakers (n=68). Transvenous pacemaker electrode placement vs. Battery replacement only was evaluated on Serum fibrin and fibrinogen degradation products (FDP) levels. Transvenous pacemaker electrode placement resulted in elevated FDP levels in a subset of patients, suggesting subclinical thrombosis, whereas battery replacement alone caused no increase.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: